Clinical Trial Update: Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

View source ↗

Summary

Postmarket evaluation of the phased radiofrequency ablation system (GOLD AF Registry) for atrial fibrillation has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Phased Radio Frequency Ablation System

Snippet

Sponsor: Medtronic Cardiac Ablation Solutions | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2020-05-01